酵母來源BETA-葡聚醣市場規模、佔有率和成長分析（按來源、類別、應用和地區分類）－產業預測（2026-2033）

預計到 2024 年，全球酵母BETA-聚葡萄糖市場規模將達到 2.183 億美元，到 2025 年將達到 2.3686 億美元，到 2033 年將達到 4.5491 億美元，預測期（2026-2033 年）的複合年成長率為 8.5%。

酵母BETA-聚葡萄糖市場正經歷著蓬勃發展，這主要得益於其作為酵母細胞壁中天然多醣的特性。這種成分在食品飲料、營養補充品、藥品和個人保健產品等多個應用領域的需求不斷成長，滿足了追求有效健康解決方案的健康意識消費者的需求。增強免疫力、降低膽固醇和改善腸道健康等關鍵益處進一步推動了市場需求。消費者對天然機能性食品的偏好日益成長，以及純素和植物性飲食趨勢的興起，都推動了市場持續成長。然而，高昂的生產成本和有限的原料供應等挑戰可能會阻礙市場成長。在製藥領域，酵母BETA-聚葡萄糖的應用前景特別廣闊，可望用於治療包括癌症和糖尿病在內的多種疾病。

全球酵母BETA-聚葡萄糖市場促進因素

酵母BETA-聚葡萄糖市場成長的關鍵因素之一是消費者對天然和有機食品日益成長的偏好。隨著健康意識的增強，人們積極尋求有助於整體健康的成分。酵母BETA-聚葡萄糖作為一種天然成分，因其促進健康的特性而備受青睞，在市場上迅速發展。為了順應消費者行為的這種變化，許多食品生產商正在研發和創新添加酵母BETA-聚葡萄糖的產品，以滿足消費者對營養健康食品替代品的需求。這一趨勢反映了人們對更健康生活方式的普遍追求，以及在飲食選擇中尋求有效天然療法的願望。

限制全球酵母BETA-聚葡萄糖市場的因素

全球酵母BETA-聚葡萄糖市場面臨的主要限制因素是其高額的生產成本。酵母BETA-聚葡萄糖生產流程複雜且成本高昂，導致整體生產成本上升。這些經濟挑戰可能會限制酵母BETA-聚葡萄糖的市場供應，從而推高價格並對市場擴張產生負面影響。因此，高生產成本和有限供應的雙重壓力可能會阻礙酵母BETA-聚葡萄糖的潛在成長和消費，給希望在各種應用領域利用其優勢的相關人員帶來挑戰。

全球酵母BETA-聚葡萄糖市場趨勢

全球酵母BETA-聚葡萄糖市場正經歷顯著成長，這主要得益於健康意識增強的消費者對植物性飲食的日益青睞。隨著人們對植物性食品的營養和環境益處的認知不斷提高，酵母BETA-聚葡萄糖作為一種天然成分，正受到追求更健康飲食方式人士的青睞。其增強免疫力和降低膽固醇等特性，與現代消費者的整體生活方式選擇高度契合。機能性食品和膳食補充劑需求的不斷成長進一步推動了這一趨勢，使酵母BETA-聚葡萄糖成為健康和保健領域的重要參與者，從而促進了市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究

全球酵母源BETA-葡聚醣市場規模（依來源及複合年成長率分類）（2026-2033年）

• 穀物和穀類
• 菇
• 海藻
• 酵母菌

全球酵母源BETA-葡聚醣市場規模（按類別分類）及複合年成長率（2026-2033年）

• 不溶物
• 水溶性

全球酵母源BETA-葡聚醣市場規模（依應用及複合年成長率分類）（2026-2033年）

• 飲食
• 個人護理及化妝品
• 製藥
• 飼料
• 其他

全球酵母源BETA-葡聚醣市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Lesaffre（France）
• Kerry Group PLC（Ireland）
• Tate & Lyle PLC（UK）
• DSM-Firmenich（Switzerland）
• Merck（US）
• Kemin Industries（US）
• Alltech（US）
• Lallemand Inc.（Canada）
• Leiber GmbH（Germany）
• Associated British Foods Plc（UK）
• Angel Yeast Co., Ltd.（China）
• Ceapro Inc.（Canada）
• Specialty Biotech Co., Ltd.（US）
• Garuda International Inc.（US）
• Biotec Pharmacon（Norway）
• NutraQ AS（Norway）
• Tateyama Kagaku Group（Japan）
• AIDP Inc.（US）
• Ohly（Germany）

結論與建議

Global Yeast Beta-Glucan Market size was valued at USD 218.3 Million in 2024 and is poised to grow from USD 236.86 Million in 2025 to USD 454.91 Million by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global yeast beta-glucan market is witnessing dynamic expansion, driven by its natural polysaccharide properties found in yeast cell walls. This ingredient is increasingly popular across diverse applications, including food and beverages, dietary supplements, pharmaceuticals, and personal care products, catering to health-conscious consumers seeking effective wellness solutions. Key benefits such as immune support, cholesterol reduction, and gut health enhancement further fuel demand. The market thrives on the rising preference for natural, functional food ingredients and aligns with growing trends like vegan and plant-based diets. However, challenges such as high production costs and limited raw material availability may hinder growth. Opportunities remain strong, particularly in the pharmaceutical sector, where yeast beta-glucan shows promise for treating various health conditions such as cancer and diabetes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Yeast Beta-Glucan market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Yeast Beta-Glucan Market Segments Analysis

Global Yeast Beta-Glucan Market is segmented by Source, Category, Application and region. Based on Source, the market is segmented into Grains & Cereal, Mushroom, Seaweed and Yeast. Based on Category, the market is segmented into Insoluble and Soluble. Based on Application, the market is segmented into Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Yeast Beta-Glucan Market

A significant factor propelling the yeast beta-glucan market is the rising consumer preference for natural and organic food options. As individuals become increasingly health-conscious, they actively seek out ingredients that contribute to their overall well-being. Yeast beta-glucan stands out as a natural component known for its health-promoting properties, garnering attention in the marketplace. This shift in consumer behavior has led many food manufacturers to innovate and create products that incorporate yeast beta-glucan, catering to the demand for nutritious and wholesome food alternatives. The trend reflects a broader commitment to healthier lifestyles and the pursuit of effective natural remedies in dietary choices.

Restraints in the Global Yeast Beta-Glucan Market

A significant limitation faced by the global yeast beta-glucan market is the elevated production expenses associated with its manufacturing. The intricate and costly processes required for producing yeast beta-glucan contribute to higher overall production costs. These financial challenges restrict the availability of yeast beta-glucan in the marketplace, resulting in increased prices that can adversely affect market expansion. Consequently, the combination of high production costs and limited accessibility may hinder the potential growth and consumption of yeast beta-glucan, posing a challenge for stakeholders seeking to capitalize on its benefits across various applications.

Market Trends of the Global Yeast Beta-Glucan Market

The Global Yeast Beta-Glucan market is experiencing a notable surge, fueled by the increasing adoption of plant-based diets among health-conscious consumers. As awareness of the nutritional and environmental benefits of plant-based eating rises, yeast beta-glucan emerges as a favored natural ingredient, appealing to those seeking healthier alternatives. Its properties, including immune support and cholesterol-lowering benefits, align well with the holistic lifestyle choices of today's consumers. This trend is further accelerated by the growing demand for functional foods and supplements, positioning yeast beta-glucan as a key player in the health and wellness sector, thereby driving market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Yeast Beta-Glucan Market Size by Source & CAGR (2026-2033)

• Market Overview
• Grains & Cereal
• Mushroom
• Seaweed
• Yeast

Global Yeast Beta-Glucan Market Size by Category & CAGR (2026-2033)

• Market Overview
• Insoluble
• Soluble

Global Yeast Beta-Glucan Market Size by Application & CAGR (2026-2033)

• Market Overview
• Food & Beverages
• Personal Care & Cosmetics
• Pharmaceuticals
• Animal Feed
• Others

Global Yeast Beta-Glucan Market Size & CAGR (2026-2033)

• North America (Source, Category, Application)
  • US
  • Canada
• Europe (Source, Category, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Source, Category, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Source, Category, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Source, Category, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Lesaffre (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tate & Lyle PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alltech (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leiber GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angel Yeast Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceapro Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Specialty Biotech Co., Ltd. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Garuda International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotec Pharmacon (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NutraQ AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tateyama Kagaku Group (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AIDP Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ohly (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations